BioCatalyst

SLS — SELLAS Life Sciences Group, Inc. catalysts

1 verified catalyst event(s) for SELLAS Life Sciences Group, Inc. (ticker SLS). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-12-30 — Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients Wit · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-30
in 3mo
ESTIMATED
 READOUT
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Pa
Phase 1/2 · Hematologic Malignancies
 SLS SELLAS Life Sciences Group, SLS009, venetoclax, azacitidine ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.